Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2017 | 03-2016 | 12-2015 | 03-2007 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 180,838 | N/A | 0 | N/A |
| Receivables | 105 | N/A | 0 | N/A |
| TOTAL | $184,164 | $N/A | $0 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 906 | N/A | 0 | N/A |
| Other Non-Current Assets | 208 | 0 | 0 | 0 |
| TOTAL | $1,114 | $N/A | $0 | $N/A |
| Total Assets | $185,278 | $N/A | $0 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 6,359 | 0 | 0 | 0 |
| Accrued Expenses | 11,978 | 223 | 0 | N/A |
| TOTAL | $18,337 | $223 | $223 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 52 | 0 | 0 | 0 |
| TOTAL | $165 | $N/A | $0 | $N/A |
| Total Liabilities | $18,502 | $223 | $223 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 60,280 | N/A | N/A | N/A |
| Common Shares | 0 | 2 | 0 | N/A |
| Retained earnings | -85,097 | -1,657 | -1,657 | N/A |
| Other shareholders' equity | 140 | -2 | 1,434 | 0 |
| TOTAL | $166,776 | $-223 | $-223 | $N/A |
| Total Liabilities And Equity | $185,278 | $0 | $0 | $0 |